These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 20008189)

  • 21. Rethinking the diagnosis of von Willebrand disease.
    Favaloro EJ
    Thromb Res; 2011 Jan; 127 Suppl 2():S17-21. PubMed ID: 21193108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of inherited von Willebrand disease in Italy: results from the retrospective study on 1234 patients.
    Federici AB; Bucciarelli P; Castaman G; Baronciani L; Canciani MT; Mazzucconi MG; Morfini M; Rocino A; Schiavoni M; Oliovecchio E; Iorio A; Mannucci PM
    Semin Thromb Hemost; 2011 Jul; 37(5):511-21. PubMed ID: 22102194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
    Michiels JJ; Gadisseur A; Budde U; Berneman Z; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and management of von Willebrand disease].
    Higasa S; Tokugawa T; Sawada A
    Rinsho Ketsueki; 2018; 59(10):2222-2232. PubMed ID: 30305529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S; Mezzasoma AM; Leone M; Gresele P
    Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease.
    Lubetsky A; Schulman S; Varon D; Martinowitz U; Kenet G; Gitel S; Inbal A
    Thromb Haemost; 1999 Feb; 81(2):229-33. PubMed ID: 10063997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology, diagnosis, and management of von Willebrand disease in India.
    Ghosh K; Shetty S
    Semin Thromb Hemost; 2011 Jul; 37(5):595-601. PubMed ID: 22102205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Von Willebrand factor (Vonvendi®): the first recombinant product licensed for the treatment of von Willebrand disease.
    Franchini M; Mannucci PM
    Expert Rev Hematol; 2016 Sep; 9(9):825-30. PubMed ID: 27427955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. von Willebrand disease and pregnancy: a practical approach for the diagnosis and treatment.
    Pacheco LD; Costantine MM; Saade GR; Mucowski S; Hankins GD; Sciscione AC
    Am J Obstet Gynecol; 2010 Sep; 203(3):194-200. PubMed ID: 20417473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive evaluation of haemostatic function in von Willebrand disease patients using a microchip-based flow chamber system.
    Ogiwara K; Nogami K; Hosokawa K; Ohnishi T; Matsumoto T; Shima M
    Haemophilia; 2015 Jan; 21(1):71-80. PubMed ID: 25545301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How I treat von Willebrand disease.
    Rodeghiero F; Castaman G; Tosetto A
    Blood; 2009 Aug; 114(6):1158-65. PubMed ID: 19474451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A personalized approach to the management of VWD.
    Phua CW; Berntorp E
    Transfus Apher Sci; 2019 Oct; 58(5):590-595. PubMed ID: 31466808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).
    Tosetto A; Rodeghiero F; Castaman G; Goodeve A; Federici AB; Batlle J; Meyer D; Fressinaud E; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Budde U; Ingerslev J; Vorlova Z; Habart D; Holmberg L; Lethagen S; Pasi J; Hill F; Peake I
    J Thromb Haemost; 2006 Apr; 4(4):766-73. PubMed ID: 16634745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mild forms of von Willebrand disease: diagnosis and management.
    Federici AB
    Curr Hematol Rep; 2003 Sep; 2(5):373-80. PubMed ID: 12932308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
    Castaman G; Federici AB; Rodeghiero F; Mannucci PM
    Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network.
    Abshire T; Cox-Gill J; Kempton CL; Leebeek FW; Carcao M; Kouides P; Donfield S; Berntorp E
    J Thromb Haemost; 2015 Sep; 13(9):1585-9. PubMed ID: 25930155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of the factor VIII/von Willebrand factor concentrate, haemate-P/humate-P: ristocetin cofactor unit dosing in patients with von Willebrand disease.
    Lillicrap D; Poon MC; Walker I; Xie F; Schwartz BA;
    Thromb Haemost; 2002 Feb; 87(2):224-30. PubMed ID: 11858481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines for the diagnosis and management of von Willebrand disease in Italy.
    Federici AB; Castaman G; Mannucci PM;
    Haemophilia; 2002 Sep; 8(5):607-21. PubMed ID: 12199668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.